工程化介酶干细胞-NK细胞复合体,用于空间向和功能复苏的癌症免疫疗法
Qian Zhang1, Bo Yin1, Munaiwaier Sabier1
1Department of Geriatric Respiratory and Critical Care, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|August 19, 2025
概括
工程干细胞-NK细胞复合体通过增强透和功能来改善固体瘤免疫疗法. 这种新型的输送系统克服了自然杀手 (NK) 细胞的局限性,以获得更好的癌症治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 癌症研究 癌症研究
背景情况:
- 自然杀手 (NK) 细胞是强大的免疫疗法,但在固体瘤中面临挑战,包括透不良和免疫抑制.
- 由于瘤微环境的敌对性质,现有的NK细胞疗法在有效性有限的情况下扎.
研究的目的:
- 开发一种工程细胞-细胞复杂传递系统,用于在固体瘤中增强NK细胞治疗.
- 为了改善NK细胞瘤定位,透和细胞毒性活性,使用IL-15表达介酶干细胞.
主要方法:
- 通过基因工程改造的脂肪衍生的介质干细胞 (SCs) 通过脂质纳米粒子介导的mRNA转染来表达介质蛋白-15 (IL-15).
- 利用生物直角点击化学,将NK细胞与工程SCs结合,形成SC-NK细胞复合体.
- 评估了SC-NK细胞复合物的疗效在正型小鼠肺癌和患者衍生的异种移植卵巢癌模型中.
主要成果:
- SC-NK 细胞复合体证明了瘤局部化的改善和持续的IL-15介导的功能增强.
- 在两种癌症模型中都观察到增强的NK细胞透和复兴的细胞毒性活性.
- 这些复合物对加勒-9阻断的反应性增加,逆转NK细胞功能障碍并增加抗瘤功效.
结论:
- 设计的SC辅助输送系统可以克服固体瘤NK细胞治疗的局限性.
- 这种方法为改善癌症免疫疗法治疗结果提供了一个有希望的策略.
- 结合SCs,NK细胞和向阻断疗法,呈现出一种新的免疫治疗途径.
更多相关视频
相关概念视频
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660


